Patents/Assignees

BIONTECH CELL & GENE THERAPIES GmbH

2 patents in portfolio

US12595292utility2026
Interleukin-2 Receptor (IL2R) and Interleukin-2 (IL2) Variants for Specific Activation of Immune Effector Cells
0 cites
US11702631utility2023
Antigen Receptors and Uses Thereof
0 cites